Monday Jan 26, 2026
Monday Jan 26, 2026
Monday, 26 January 2026 04:53 - - {{hitsCtrl.values.hits}}
The financial contribution was formally presented by the SLCPI Executive Committee to Health and Mass Media Minister Dr. Nalinda Jayatissa at the Health and Mass Media Ministry recently. The SLCPI delegation was led by SLCPI President and Sunshine Healthcare Lanka Executive Director Shantha Bandara, together with other office bearers of the Chamber, including Past President Myilvaganam Prathahaban, Vice Presidents Nishantha Weerasinghe and Dr. Mahesha Ranasoma, and Secretary Ivin Jesumani
The Sri Lanka Chamber of the Pharmaceutical Industry (SLCPI) has donated Rs. 50 million to the Government’s ‘Rebuilding Sri Lanka’ Fund, established to support national recovery efforts following the recent disaster.
The SLCPI noted that the donation is intended to support efforts to strengthen health services and assist in rebuilding essential infrastructure. The Chamber further stated that the contribution will support the Ministry’s disaster management activities and help ensure that critical public services, including healthcare, can continue without disruption during the recovery period.
SLCPI President Shantha Bandara said: “Sri Lanka’s recovery will depend on keeping essential services running while rebuilding what has been damaged. Through this contribution, the pharmaceutical industry is supporting the immediate needs of disaster response and the longer-term work of restoring resilience across the health system. It is a collective commitment from our members to act responsibly, mobilise support at scale, and contribute to national rebuilding in a practical way.”
Health and Mass Media Minister Dr. Nalinda Jayatissa said: “We appreciate the SLCPI’s contribution to the ‘Rebuilding Sri Lanka’ Fund. Support of this nature is important to sustain essential health services during times of national challenge and to strengthen service delivery as recovery efforts move forward.”
The SLCPI serves as the apex representative body for over 70 member companies, comprising importers, manufacturers, distributors, and retailers, who collectively account for more than 80% of the island’s private pharmaceutical market. The industry directly employs over 80,000 individuals and indirectly supports nearly 400,000 more, making it a vital contributor to the national economy and healthcare delivery.
